SCHEMBL6910035

SCHEMBL6910035

O=C(O)c1ccc(O)c(O)c1C(=O)O.O=C(O)c1ccc(O)cc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.60
CA1 P00915 3/20 0.60
CA2 P00918 3/20 0.60
CA7 P43166 3/20 0.60
CA9 Q16790 3/20 0.60
CA14 Q9ULX7 3/20 0.60
PTGS2 P35354 2/20 0.60
ALOX5 P09917 1/20 0.60
ALDH1A1 P00352 3/20 0.55
TSHR P16473 1/20 0.55
SELL P14151 1/20 0.52
SELP P16109 1/20 0.52
TDP1 Q9NUW8 3/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HSD17B10 Q99714 3/20 0.44
CES2 O00748 1/20 0.42
LCK P06239 3/20 0.42
EGFR P00533 2/20 0.42
MEN1 O00255 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157512 0.87 SELL (0.67) CA12CA1CA2CA7CA9
SCHEMBL29404142 0.87 SELL (0.67) CA12CA1CA2CA7CA9
SCHEMBL28558475 0.85 SELL (0.71) CA12CA1CA2CA7CA9
SCHEMBL28558473 0.85 SELL (0.64) CA12CA1CA2CA7CA9
Ammonia Solution, Strong SCHEMBL28928633 0.85 SELL (0.64) CA12CA1CA2CA7CA9
SCHEMBL11334631 0.83 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL177949 0.82 ALDH1A1 (0.70) CA12CA1CA2CA7CA9
SCHEMBL31298798 0.82 ALDH1A1 (0.70) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL11161670 0.80 ALDH1A1 (0.67) CA12CA1CA2CA7CA9
SCHEMBL31390818 0.80 ALDH1A1 (0.67) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730810-B2 HOMOGENOUS MIXTURE COMPRISING ACID HALIDE WITH HYDROXY CARBOXYLIC ACIDS AND ANHYDRIDE; DISCOLORATION INHIBITION HUNTSMAN PETROCHEMICAL CORPORATION 2004-05-04 US disclosed
US-6603042-B2 Mixing acid halide and hydroxycarboxylic acid with maleic acid anhydride forming homogeneous solution having reduced tendency to discolor HUNTSMAN PETROCHEMICAL CORPORATION 2003-08-05 US disclosed
US-6593495-B1 Anhydride stabilization HUNTSMAN PETROCHEMICAL CORPORATION 2003-07-15 US disclosed
US-20030120089-A1 Anhydride stabilization HUNTSMAN PETROCHEMICAL CORPORATION 2003-06-26 US disclosed
EP-1144354-B1 ANHYDRIDE STABILIZATION HUNTSMAN SPEC CHEM CORP (US) 2003-05-14 EP disclosed
US-20030083522-A1 Anhydride stabilization HUNTSMAN PETROCHEMICAL CORPORATION 2003-05-01 US disclosed
EP-1144354-A1 ANHYDRIDE STABILIZATION HUNTSMAN PETROCHEMICAL CORPORATION (US) 2001-10-17 EP disclosed
WO-2000041991-A1 ANHYDRIDE STABILIZATION HUNTSMAN PETROCHEMICAL CORPORATION (US) 2000-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120089-A1 Anhydride stabilization CA7, CA4, CA9 CA12 5/4885CA1 8/4885CA2 4/4885
US-20030083522-A1 Anhydride stabilization CA7, CA4, CA9 CA12 5/4885CA1 8/4885CA2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.